rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2005-1-28
|
pubmed:abstractText |
Several studies have demonstrated that endothelial dysfunction plays a central role in diabetic mortality and that the prooxidative effect of postprandial hyperglycemia may actively contribute to atherogenesis. Thus, we investigated the possible effect of short-acting (repaglinide) and long-acting (glibenclamide) insulin secretagogues on endothelial function in type 2 diabetic patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0149-5992
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
366-71
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15677794-Aged,
pubmed-meshheading:15677794-Blood Glucose,
pubmed-meshheading:15677794-Brachial Artery,
pubmed-meshheading:15677794-Carbamates,
pubmed-meshheading:15677794-Cross-Over Studies,
pubmed-meshheading:15677794-Diabetes Mellitus, Type 2,
pubmed-meshheading:15677794-Diabetic Angiopathies,
pubmed-meshheading:15677794-Endothelium, Vascular,
pubmed-meshheading:15677794-Female,
pubmed-meshheading:15677794-Glyburide,
pubmed-meshheading:15677794-Humans,
pubmed-meshheading:15677794-Hypoglycemic Agents,
pubmed-meshheading:15677794-Male,
pubmed-meshheading:15677794-Middle Aged,
pubmed-meshheading:15677794-Oxidative Stress,
pubmed-meshheading:15677794-Piperidines
|
pubmed:year |
2005
|
pubmed:articleTitle |
Repaglinide administration improves brachial reactivity in type 2 diabetic patients.
|
pubmed:affiliation |
Department of Geriatric Medicine and Metabolic Diseases VI, Internal Medicine, Piazza Miraglia 2 I-80138, Napoli, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|